Amy Abernethy, the principal deputy commissioner of the US Food and Drug Administration, is leaving the agency, according to a letter from acting commissioner Janet Woodcock. The surprise news comes in the midst of the Biden administration still deciding on their nominee to lead the agency.
Abernethy was recruited to the FDA from the private sector by former commissioner Scott Gottlieb. It was widely reported that she was being groomed to take the helm following his...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?